Generation Bio Co. is a genetic medicines company headquartered in Cambridge, Massachusetts. It specializes in developing therapies for rare and prevalent diseases of the liver, retina, skeletal muscle, central nervous system, and oncology. It was previously called Torus Therapeutics, Inc., and changed its name in November 2017.